EU and industry-funded research into validating more imaging biomarkers for use in cancer drug trials seeks to speed up development of successful new drugs and avoid exposing patients to treatment that does not work for them.
Results of the Public Consultation on Transformation of Health and Care in the Digital Single Market
The public consultation drew nearly 1.500 replies and showed a broad support for health related actions in the Digital Single Market. More than 90% of respondents agree that citizens should be able to manage their own data. More than 80% agree that sharing health data can be beneficial. Nearly 55% report not having access to digital health services. More than 80% agree that citizen feedback to healthcare providers and professionals is essential to improve services.
IMI – new brochure on results and projects
The projects supported by the Innovative Medicines Initiative (IMI) are laying the foundations that are helping researchers across Europe, including many in SMEs, to advance their drug development programmes. As of the end of 2016, the IMI community brought together 11. 500 scientists and experts from across Europe and beyond working in 84 projects. Find out more about IMI's commitment towards helping to fast-track medical breakthroughs in their new brochure on results and projects.
Evaluation of the Innovative Medicines Initiative now published
The reports on the evaluation of the seven public-private partnerships, the so-called Joint Undertakings (JUs) under Horizon 2020, and their six predecessors under the previous seventh framework programme, have been published. This includes a Staff Working Document presenting the Commission services' view on the performance of the seven JUs under Horizon 2020. The experts concluded that the Innovative Medicines Initiative “remains both relevant and justified” under Horizon 2020 and that “positive contributions on the drug development process are expected, but results are yet to be realised as the first projects under IMI2 JU only started in 2014”.
- Staff Working Document
- Report on IMI JU Final Evaluation
- Report on IMI2 JU Interim Evaluation
- News Alert
EU–funded project aims at developing an effective Tuberculosis vaccine
Supported by Horizon 2020 with EUR 18.2m, TBVAC2020 research project aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. Over 50% of the global pipeline in TB vaccine candidates currently evaluated in clinical trials originate from EU–funded projects. The European Commission has played a key leadership role in accelerating TB vaccine research and development and ensured a well-coordinated and efficient TB vaccine research consortium.
Registration open! Health, demographic change and wellbeing Info Day
8 December 2017, Brussels
With the principle of better health for all at its core, Horizon 2020's Societal Challenge 1 (Health, demographic change and wellbeing) will be presented during the Health Information Day on 8 December 2017 in Brussels. Societal Challenge 1 (expected budget approx.. EUR 2 billion) focuses on personalised health and care, infectious diseases and improving global health, innovative and sustainable health systems, decoding the role of the environment (including climate change) for health and wellbeing, digital transformation and cybersecurity in health and care.
Related to the Health Open Info Day, the Directorate-General for Research & Innovation supports two events organised on 7 December 2017 (Brussels): Innovation Procurement in health care and the Partnering Event coordinated by the EU–funded project Health-NCP-Net 2.0.
Directorate-General Research & Innovation at the European Health Forum Gastein
DG Research & Innovation invites you to take part in the two interactive sessions organised at the European Health Forum Gastein:
- 4 October, 9:00-11:00, Personalising healthcare: How rare diseases pave the way
- 5 October, 16:00-18:30, Environment & health: Building the evidence base for policy
EU-funded project ALIVER produces new dialysis technology
EU-funded project ALIVER has developed and optimised a novel liver dialysis device called DIALIVE. By 2020 a new dialysis technology could be available and extend the lives of people with cirrhosis long enough for their liver to start recovering or to find a donor for a liver transplant.
24 October 2017, Brussels, Belgium - Science Café with Cyril Höschl
24-27 October 2017, Berlin, Germany - DKOU 2017 - German Congress of Orthopedic and Trauma Surgery